查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
手术后疼痛治疗药的全球市场:各药物类别 - 产业分析，规模，占有率，成长，趋势，预测(2022年～2031年)
市场调查报告书
商品编码
1140653

手术后疼痛治疗药的全球市场:各药物类别 - 产业分析，规模，占有率，成长，趋势，预测(2022年～2031年)

Post-operative Pain Therapeutics Market (Drug Class: NSAIDs, Opioids, Local Anesthetics, Antiepileptic Drugs, Tricyclic Antidepressants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

本报告提供全球手术后疼痛治疗药市场相关调查分析，提供市场趋势，市场区隔分析，地区分析，企业简介等资讯。

目录

第1章 序文

第2章 前提与调查手法

第3章 摘要整理:全球手术后疼痛治疗药市场

第4章 市场概要

  • 简介
    • 市场区隔定义
  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会

第5章 主要考察

  • 手术数量(整形外科，一般手术，整形外科，妇产科，眼科等)(2020年～2021年)
    • 北美(美国·加拿大)
    • 欧洲联盟(德国·英国·法国·义大利·西班牙)
    • 亚太地区(日本·中国·印度·新加坡·韩国)
    • 南美(巴西·墨西哥·阿根廷)
  • 产品分析 - 包装，尺寸，价格
  • 主要的产业的发展
  • 开发平台分析
  • 法规情景的评估
  • 术后管理必要的所有手术概要
    • 手术后疼痛管理必要的美国的手术
  • COVID-19影响的分析

第6章 全球手术后疼痛治疗药市场分析与预测:各药物类别

  • 简介和定义
  • 主要调查结果/发展
  • 市场金额的预测:各药物类别(2017年～2031年)
    • 类鸦片物质
    • NSAID
    • 局部麻醉剂
    • 三环抗忧郁药物
    • 抗癫痫药
    • 其他
  • 市场魅力分析:各药物类别

第7章 全球手术后疼痛治疗药市场分析与预测:各给药途径

  • 简介和定义
  • 主要调查结果/发展
  • 市场金额的预测:各给药途径(2017年～2031年)
    • 口服
    • 静脉
    • 肌肉
    • 其他
  • 市场魅力分析:各给药途径

第8章 全球手术后疼痛治疗药市场分析与预测:各流通管道

  • 简介和定义
  • 主要调查结果/发展
  • 市场金额的预测:各流通管道(2017年～2031年)
    • 医院药局
    • 零售药局
    • 线上药局
    • 其他
  • 市场魅力分析:各流通管道

第9章 全球手术后疼痛治疗药市场分析与预测:各地区

  • 主要调查结果
  • 市场金额的预测:各地区
    • 美国
    • 欧洲联盟(EU5个国家)
    • 亚太地区
    • 南美
    • 其他地区(RoW)
  • 市场魅力分析:各地区

第10章 美国的手术后疼痛治疗药市场分析与预测

  • 简介
    • 主要调查结果
  • 市场金额的预测:各药物类别(2017年～2031年)
  • 市场金额的预测:各给药途径(2017年～2031年)
  • 市场金额的预测:各流通管道(2017年～2031年)
  • 市场金额的预测:各国(2017年～2031年)
  • 市场魅力分析
    • 各药物类别
    • 各给药途径
    • 各流通管道

第11章 欧洲联盟(EU5个国家)的手术后疼痛治疗药市场分析与预测

第12章 亚太地区的手术后疼痛治疗药市场分析与预测

第13章 南美的手术后疼痛治疗药市场分析与预测

第14章 其他地区(RoW)的手术后疼痛治疗药市场分析与预测

第15章 竞争情形

  • 竞争的事业策略
  • 企业简介
    • Mallinckrodt Pharmaceuticals
    • Pfizer, Inc.
    • Novartis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd.
    • Camurus AB
    • Bayer AG
    • Pacira BioSciences, Inc.
    • Trevena, Inc.
Product Code: TMRGL67271

The report provides revenue of the global post-operative pain therapeutics market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global post-operative pain therapeutics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the post-operative pain therapeutics market.

The report delves into the competitive landscape of the global post-operative pain therapeutics market. Key players operating in the global post-operative pain therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global post-operative pain therapeutics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Post-operative Pain Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities

5. Key Insights

  • 5.1. No. of Surgical Procedure Volume, (Orthopedic Surgery, General Surgery, Plastic Surgery, Gynecological Surgery, Ophthalmic Surgery etc.), 2020-2021
    • 5.1.1. North America (U.S. and Canada)
    • 5.1.2. European Union (Germany, U.K. France, Italy and Spain)
    • 5.1.3. Asia Pacific (Japan, China, India, Singapore and Korea)
    • 5.1.4. Latin America (Brazil, Mexico and Argentina)
  • 5.2. Product Analysis- Packaging, Size, and Price
  • 5.3. Key Industry Development
  • 5.4. Pipeline Analysis
  • 5.5. Regulatory Scenario Assessment
  • 5.6. Overview of Total Surgical Procedures Requiring Postoperative Management
    • 5.6.1. U.S. Surgical Procedures Requiring Postoperative Pain Management
  • 5.7. COVID-19 Impact Analysis

6. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Drug Class, 2017-2031
    • 6.3.1. Opioids
    • 6.3.2. NSAIDs
    • 6.3.3. Local Anesthetics
    • 6.3.4. Tricyclic Antidepressants
    • 6.3.5. Antiepileptic Drugs
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 7.3.1. Oral
    • 7.3.2. Intravenous
    • 7.3.3. Intramuscular
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. U.S.
    • 9.2.2. European Union (EU5)
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Rest of the World (RoW)
  • 9.3. Market Attractiveness Analysis, by Region

10. U.S. Post-operative Pain Therapeutics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Drug Class, 2017-2031
    • 10.2.1. Opioids
    • 10.2.2. NSAIDs
    • 10.2.3. Local Anesthetics
    • 10.2.4. Tricyclic Antidepressants
    • 10.2.5. Antiepileptic Drugs
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 10.3.1. Oral
    • 10.3.2. Intravenous
    • 10.3.3. Intramuscular
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel

11. European Union (EU5) Post-operative Pain Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Drug Class, 2017-2031
    • 11.2.1. Opioids
    • 11.2.2. NSAIDs
    • 11.2.3. Local Anesthetics
    • 11.2.4. Tricyclic Antidepressants
    • 11.2.5. Antiepileptic Drugs
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 11.3.1. Oral
    • 11.3.2. Intravenous
    • 11.3.3. Intramuscular
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. France
    • 11.5.3. U.K.
    • 11.5.4. Italy
    • 11.5.5. Spain
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Class
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Post-operative Pain Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2017-2031
    • 12.2.1. Opioids
    • 12.2.2. NSAIDs
    • 12.2.3. Local Anesthetics
    • 12.2.4. Tricyclic Antidepressants
    • 12.2.5. Antiepileptic Drugs
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.3.1. Oral
    • 12.3.2. Intravenous
    • 12.3.3. Intramuscular
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. South Korea
    • 12.5.4. Singapore
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Class
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Post-operative Pain Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2017-2031
    • 13.2.1. Opioids
    • 13.2.2. NSAIDs
    • 13.2.3. Local Anesthetics
    • 13.2.4. Tricyclic Antidepressants
    • 13.2.5. Antiepileptic Drugs
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.3.1. Oral
    • 13.3.2. Intravenous
    • 13.3.3. Intramuscular
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Argentina
    • 13.5.3. Chile
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Class
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Rest of the World (RoW) Post-operative Pain Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Class, 2017-2031
    • 14.2.1. Opioids
    • 14.2.2. NSAIDs
    • 14.2.3. Local Anesthetics
    • 14.2.4. Tricyclic Antidepressants
    • 14.2.5. Antiepileptic Drugs
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.3.1. Oral
    • 14.3.2. Intravenous
    • 14.3.3. Intramuscular
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country, 2017-2031
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Class
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel

15. Competition Landscape

  • 15.1. Competitive Business Strategies
  • 15.2. Company Profiles
    • 15.2.1. Mallinckrodt Pharmaceuticals
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. SWOT Analysis
      • 15.2.1.4. Strategic Overview
    • 15.2.2. Pfizer, Inc.
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. SWOT Analysis
      • 15.2.2.4. Strategic Overview
    • 15.2.3. Novartis AG
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. SWOT Analysis
      • 15.2.3.4. Strategic Overview
    • 15.2.4. Eli Lilly and Company
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. SWOT Analysis
      • 15.2.4.4. Strategic Overview
    • 15.2.5. Teva Pharmaceutical Industries Ltd.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. SWOT Analysis
      • 15.2.5.4. Strategic Overview
    • 15.2.6. Camurus AB
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. SWOT Analysis
      • 15.2.6.4. Strategic Overview
    • 15.2.7. Bayer AG
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. SWOT Analysis
      • 15.2.7.4. Strategic Overview
    • 15.2.8. Pacira BioSciences, Inc.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. SWOT Analysis
      • 15.2.8.4. Strategic Overview
    • 15.2.9. Trevena, Inc.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. SWOT Analysis
      • 15.2.9.4. Strategic Overview

List of Tables

  • Table 01: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 02: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 03: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 06: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 07: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 08: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 10: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 14: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 15: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 17: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 18: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 19: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 21: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 22: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 02: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 03: Global Post-operative Pain Therapeutics Market (US$ Mn), by Opioids, 2017-2031
  • Figure 04: Global Post-operative Pain Therapeutics Market (US$ Mn), by NSAIDs, 2017-2031
  • Figure 05: Global Post-operative Pain Therapeutics Market (US$ Mn), by Local Anesthetics, 2017-2031
  • Figure 06: Global Post-operative Pain Therapeutics Market (US$ Mn), by Tricyclic Antidepressants, 2017-2031
  • Figure 07: Global Post-operative Pain Therapeutics Market (US$ Mn), by Antiepileptic Drugs, 2017-2031
  • Figure 08: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 10: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 11: Global Post-operative Pain Therapeutics Market (US$ Mn), by Oral, 2017-2031
  • Figure 12: Global Post-operative Pain Therapeutics Market (US$ Mn), by Intravenous, 2017-2031
  • Figure 13: Global Post-operative Pain Therapeutics Market (US$ Mn), by Intramuscular, 2017-2031
  • Figure 14: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 15: Global Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 16: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 17: Global Post-operative Pain Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 18: Global Post-operative Pain Therapeutics Market (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 19: Global Post-operative Pain Therapeutics Market (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 20: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 21: Global Post-operative Pain Therapeutics Market, by Region, 2021 and 2031
  • Figure 22: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 23: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: U.S. Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 25: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 26: U.S. Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 27: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 28: U.S. Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 29: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 30: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: European Union (EU5) Post-operative Pain Therapeutics Market, by Country/Region, 2021 and 2031
  • Figure 32: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country/Region, 2022-2031
  • Figure 33: European Union (EU5) Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 34: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 35: European Union (EU5) Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 36: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 37: European Union (EU5) Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 38: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 39: Asia Pacific Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Asia Pacific Post-operative Pain Therapeutics Market, by Country, 2021 and 2031
  • Figure 41: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 42: Asia Pacific Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 43: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 44: Asia Pacific Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 45: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 46: Asia Pacific Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 47: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 48: Latin America Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Latin America Post-operative Pain Therapeutics Market, by Country, 2021 and 2031
  • Figure 50: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 51: Latin America Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 52: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 53: Latin America Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 54: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 55: Latin America Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 56: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 57: Rest of the World Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 58: Rest of the World Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 59: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 60: Rest of the World Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 61: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 62: Rest of the World Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 63: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031